Last 12 months
Inside the activity.
9 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 1 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 4 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 29, 2026 Filed Jun 2, 2026 20:09 UTC |
Chiminski John RDirector
|
GrantCommon Stock | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001482197-26-000002 · wk-form4_1780430962.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,352 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:09 UTC |
BUECHLER KENNETH FDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001238916-26-000002 · wk-form4_1780430986.xml · derivative · entry 2 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,829 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 29, 2026. F3 · derivative.expiration_date: The restricted stock units vested on May 29, 2026. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:09 UTC |
BUECHLER KENNETH FDirector
|
GrantCommon Stock | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001238916-26-000002 · wk-form4_1780430986.xml · nonDerivative · entry 1 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,750 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:10 UTC |
POLAN MARY LAKE PH DDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001187716-26-000002 · wk-form4_1780431016.xml · derivative · entry 3 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,829 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 29, 2026. F3 · derivative.expiration_date: The restricted stock units vested on May 29, 2026. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:10 UTC |
POLAN MARY LAKE PH DDirector
|
GrantCommon Stock | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001187716-26-000002 · wk-form4_1780431016.xml · nonDerivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,469 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:07 UTC |
RHOADS ANN DDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001250252-26-000006 · wk-form4_1780430859.xml · derivative · entry 2 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,829 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 29, 2026. F3 · derivative.expiration_date: The restricted stock units vested on May 29, 2026. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:07 UTC |
RHOADS ANN DDirector
|
GrantCommon Stock | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001250252-26-000006 · wk-form4_1780430859.xml · nonDerivative · entry 1 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,257 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:08 UTC |
Huennekens R ScottDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001365493-26-000005 · wk-form4_1780430930.xml · derivative · entry 2 Huennekens R Scott · CIK 0001365493 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,829 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 29, 2026. F3 · derivative.expiration_date: The restricted stock units vested on May 29, 2026. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:08 UTC |
Huennekens R ScottDirector
|
GrantCommon Stock | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001365493-26-000005 · wk-form4_1780430930.xml · nonDerivative · entry 1 Huennekens R Scott · CIK 0001365493 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,352 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:11 UTC |
Strobeck MatthewDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001377832-26-000005 · wk-form4_1780431068.xml · derivative · entry 4 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,829 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: The restricted stock units vested on May 29, 2026. F5 · derivative.expiration_date: The restricted stock units vested on May 29, 2026. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:11 UTC |
Strobeck MatthewDirector
|
GrantCommon Stock | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001377832-26-000005 · wk-form4_1780431068.xml · nonDerivative · entry 1 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,604 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:06 UTC |
Dilsaver Evelyn SDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001391387-26-000005 · wk-form4_1780430781.xml · derivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,829 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 29, 2026. F3 · derivative.expiration_date: The restricted stock units vested on May 29, 2026. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:06 UTC |
Dilsaver Evelyn SDirector
|
GrantCommon Stock | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001391387-26-000005 · wk-form4_1780430781.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,453 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:07 UTC |
Michael Edward L.Director
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001391823-26-000002 · wk-form4_1780430829.xml · derivative · entry 2 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,829 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 29, 2026. F3 · derivative.expiration_date: The restricted stock units vested on May 29, 2026. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:07 UTC |
Michael Edward L.Director
|
GrantCommon Stock | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001391823-26-000002 · wk-form4_1780430829.xml · nonDerivative · entry 1 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,181 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:08 UTC |
Wilkins Joseph D Jr.Director
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001848760-26-000002 · wk-form4_1780430901.xml · derivative · entry 2 Wilkins Joseph D Jr. · CIK 0001848760 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,829 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 29, 2026. F3 · derivative.expiration_date: The restricted stock units vested on May 29, 2026. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:08 UTC |
Wilkins Joseph D Jr.Director
|
GrantCommon Stock | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001848760-26-000002 · wk-form4_1780430901.xml · nonDerivative · entry 1 Wilkins Joseph D Jr. · CIK 0001848760 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,705 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:07 UTC |
RHOADS ANN DDirector
|
Exercise / conversionRestricted Stock Units (Premium) · Derivative | 234 | $0.00 | $0.00 |
DisclosureSEC source: 0001250252-26-000004 · wk-form4_1779912440.xml · derivative · entry 4 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 234 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:07 UTC |
RHOADS ANN DDirector
|
Exercise / conversionRestricted Stock Units (Converted) · Derivative | 1,173 | $0.00 | $0.00 |
DisclosureSEC source: 0001250252-26-000004 · wk-form4_1779912440.xml · derivative · entry 3 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,173 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:07 UTC |
RHOADS ANN DDirector
|
GrantCommon Stock | 234 | $0.00 | $0.00 |
DisclosureSEC source: 0001250252-26-000004 · wk-form4_1779912440.xml · nonDerivative · entry 2 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,428 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:07 UTC |
RHOADS ANN DDirector
|
GrantCommon Stock | 1,173 | $0.00 | $0.00 |
DisclosureSEC source: 0001250252-26-000004 · wk-form4_1779912440.xml · nonDerivative · entry 1 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,194 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:05 UTC |
Blaser Brian J.President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 20,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001492289-26-000008 · wk-form4_1779221140.xml · derivative · entry 4 Blaser Brian J. · CIK 0001492289 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,759 Underlying: Common Stock · 20,759 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 20,759 shares vested on each of May 15, 2025 and May 15, 2026; the remaining 20,759 shares will vest on May 15, 2027. F4 · derivative.expiration_date: 20,759 shares vested on each of May 15, 2025 and May 15, 2026; the remaining 20,759 shares will vest on May 15, 2027. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:05 UTC |
Blaser Brian J.President and CEO
|
Tax withholdingCommon Stock | 10,252 | $10.32 | $105,800.64 |
DisclosureSEC source: 0001492289-26-000008 · wk-form4_1779221140.xml · nonDerivative · entry 2 Blaser Brian J. · CIK 0001492289 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,649 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:05 UTC |
Blaser Brian J.President and CEO
|
GrantCommon Stock | 20,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001492289-26-000008 · wk-form4_1779221140.xml · nonDerivative · entry 1 Blaser Brian J. · CIK 0001492289 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,901 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 3. Read SEC document |
| April 26, 2026 Filed Apr 28, 2026 20:10 UTC |
McLellan Philip D.Chief Operations Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,946 | $0.00 | $0.00 |
DisclosureSEC source: 0002045799-26-000008 · wk-form4_1777407049.xml · derivative · entry 3 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,946 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 1,945 shares vested on April 26, 2025; the remaining 1,946 shares vested on April 26, 2026. F4 · derivative.expiration_date: 1,945 shares vested on April 26, 2025; the remaining 1,946 shares vested on April 26, 2026. Read SEC document |
| April 26, 2026 Filed Apr 28, 2026 20:10 UTC |
McLellan Philip D.Chief Operations Officer
|
Tax withholdingCommon Stock | 699 | $11.59 | $8,101.41 |
DisclosureSEC source: 0002045799-26-000008 · wk-form4_1777407049.xml · nonDerivative · entry 2 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,497 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| April 26, 2026 Filed Apr 28, 2026 20:10 UTC |
McLellan Philip D.Chief Operations Officer
|
GrantCommon Stock | 1,946 | $0.00 | $0.00 |
DisclosureSEC source: 0002045799-26-000008 · wk-form4_1777407049.xml · nonDerivative · entry 1 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,196 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 3. Read SEC document |
| April 26, 2026 Filed Apr 28, 2026 20:12 UTC |
Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
|
Exercise / conversionRestricted Stock Units · Derivative | 1,459 | $0.00 | $0.00 |
DisclosureSEC source: 0002123618-26-000007 · wk-form4_1777407132.xml · derivative · entry 3 Hanson Bryan Michael · CIK 0002123618 · EVP Global Port. Mgmt & Mkting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,459 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 1,459 shares vested on April 26, 2026. F4 · derivative.expiration_date: 1,459 shares vested on April 26, 2026. Read SEC document |
| April 26, 2026 Filed Apr 28, 2026 20:12 UTC |
Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
|
Tax withholdingCommon Stock | 528 | $11.59 | $6,119.52 |
DisclosureSEC source: 0002123618-26-000007 · wk-form4_1777407132.xml · nonDerivative · entry 2 Hanson Bryan Michael · CIK 0002123618 · EVP Global Port. Mgmt & Mkting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,070 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| April 26, 2026 Filed Apr 28, 2026 20:12 UTC |
Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
|
GrantCommon Stock | 1,459 | $0.00 | $0.00 |
DisclosureSEC source: 0002123618-26-000007 · wk-form4_1777407132.xml · nonDerivative · entry 1 Hanson Bryan Michael · CIK 0002123618 · EVP Global Port. Mgmt & Mkting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,598 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 3. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:07 UTC |
McLellan Philip D.Chief Operations Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,238 | $0.00 | $0.00 |
DisclosureSEC source: 0002045799-26-000006 · wk-form4_1777061272.xml · derivative · entry 3 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,238 Underlying: Common Stock · 3,238 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 3,238 shares vested on April 22, 2026; the remaining 3,238 shares will vest on April 22, 2027. F4 · derivative.expiration_date: 3,238 shares vested on April 22, 2026; the remaining 3,238 shares will vest on April 22, 2027. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:07 UTC |
McLellan Philip D.Chief Operations Officer
|
Tax withholdingCommon Stock | 1,162 | $11.90 | $13,827.80 |
DisclosureSEC source: 0002045799-26-000006 · wk-form4_1777061272.xml · nonDerivative · entry 2 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,250 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:07 UTC |
McLellan Philip D.Chief Operations Officer
|
GrantCommon Stock | 3,238 | $0.00 | $0.00 |
DisclosureSEC source: 0002045799-26-000006 · wk-form4_1777061272.xml · nonDerivative · entry 1 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,412 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:07 UTC |
Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
|
Exercise / conversionRestricted Stock Units · Derivative | 3,508 | $0.00 | $0.00 |
DisclosureSEC source: 0002123618-26-000005 · wk-form4_1777061238.xml · derivative · entry 3 Hanson Bryan Michael · CIK 0002123618 · EVP Global Port. Mgmt & Mkting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,508 Underlying: Common Stock · 3,508 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 3,508 shares vested on April 22, 2026; the remaining 3,508 shares will vest on April 22, 2027. F4 · derivative.expiration_date: 3,508 shares vested on April 22, 2026; the remaining 3,508 shares will vest on April 22, 2027. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:07 UTC |
Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
|
Tax withholdingCommon Stock | 1,269 | $11.90 | $15,101.10 |
DisclosureSEC source: 0002123618-26-000005 · wk-form4_1777061238.xml · nonDerivative · entry 2 Hanson Bryan Michael · CIK 0002123618 · EVP Global Port. Mgmt & Mkting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,139 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:07 UTC |
Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
|
GrantCommon Stock | 3,508 | $0.00 | $0.00 |
DisclosureSEC source: 0002123618-26-000005 · wk-form4_1777061238.xml · nonDerivative · entry 1 Hanson Bryan Michael · CIK 0002123618 · EVP Global Port. Mgmt & Mkting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,408 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 3. Read SEC document |
| April 15, 2026 Filed Apr 22, 2026 18:14 UTC |
SISITSKY NATHANIELChief Legal Officer
|
GrantNon-Qualified Stock Options · Derivative | 73,434 | $0.00 Strike: $17.49 | $0.00 |
DisclosureSEC source: 0001225738-26-000007 · wk-form4_1776896045.xml · derivative · entry 2 SISITSKY NATHANIEL · CIK 0001225738 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,434 Underlying: Common Stock · 73,434 shares Expires 2036-04-15 F3 · derivative.exercise_date: 24,478 shares will vest in equal installments on April 15, 2027, April 15, 2028 and April 15, 2029. Read SEC document |
| April 15, 2026 Filed Apr 22, 2026 18:14 UTC |
SISITSKY NATHANIELChief Legal Officer
|
GrantRestricted Stock Units · Derivative | 73,435 | $0.00 | $0.00 |
DisclosureSEC source: 0001225738-26-000007 · wk-form4_1776896045.xml · derivative · entry 1 SISITSKY NATHANIEL · CIK 0001225738 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,435 Underlying: Common Stock · 73,435 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: 24,478 shares will vest in equal installments on April 15, 2027 and April 15, 2028; the remaining 24,479 shares will vest on April 15, 2029. F2 · derivative.expiration_date: 24,478 shares will vest in equal installments on April 15, 2027 and April 15, 2028; the remaining 24,479 shares will vest on April 15, 2029. Read SEC document |
| March 28, 2026 Filed Mar 31, 2026 16:14 UTC |
Busky Joseph M.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001385091-26-000012 · wk-form4_1774988038.xml · derivative · entry 4 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,925 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 14,775 shares vested in equal installments on March 28, 2024, March 28, 2025 and March 28, 2026. F4 · derivative.expiration_date: 14,775 shares vested in equal installments on March 28, 2024, March 28, 2025 and March 28, 2026. Read SEC document |
| March 28, 2026 Filed Mar 31, 2026 16:14 UTC |
Busky Joseph M.Chief Financial Officer
|
Tax withholdingCommon Stock | 1,519 | $14.78 | $22,450.82 |
DisclosureSEC source: 0001385091-26-000012 · wk-form4_1774988038.xml · nonDerivative · entry 2 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,818 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| March 28, 2026 Filed Mar 31, 2026 16:14 UTC |
Busky Joseph M.Chief Financial Officer
|
GrantCommon Stock | 4,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001385091-26-000012 · wk-form4_1774988038.xml · nonDerivative · entry 1 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,337 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 13, 2026 Filed Feb 13, 2026 15:43 UTC |
Blaser Brian J.President and CEO
|
PurchaseCommon Stock | 10,540 | $23.59 | $248,660.73 |
DisclosureSEC source: 0001492289-26-000006 · wk-form4_1770997380.xml · nonDerivative · entry 1 Blaser Brian J. · CIK 0001492289 · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 40,073 F1 · price: The weighted average purchase price of these transactions was $23.5921 per share, with a range of $23.4200 to $23.9400 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 13, 2026 Filed Feb 13, 2026 21:20 UTC |
Strobeck MatthewDirector
|
PurchaseCommon Stock | 10,000 | $23.96 | $239,586.00 |
DisclosureSEC source: 0001377832-26-000003 · wk-form4_1771017605.xml · nonDerivative · entry 1 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,775 F1 · price: The weighted average purchase price of these transactions was $23.9586 per share, with a range of $23.7600 to $23.9999 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 13, 2026 Filed Feb 13, 2026 12:44 UTC |
Busky Joseph M.Chief Financial Officer
|
PurchaseCommon Stock | 3,370 | $23.66 | $79,741.95 |
DisclosureSEC source: 0001385091-26-000008 · wk-form4_1771004668.xml · nonDerivative · entry 1 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 10,290 Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 16:18 UTC Amendment |
Busky Joseph M.Chief Financial Officer
|
PurchaseCommon Stock | 3,370 | $23.66 | $79,741.95 |
DisclosureSEC source: 0001385091-26-000010 · wk-form4a_1771535883.xml · nonDerivative · entry 1 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 10,290 F1 · price: The Form 4 originally filed on February 13, 2026 is being amended to report the correct pricing of the shares purchased by the Reporting Person. The weighted average purchase price of these transactions was $23.6623 per share, with a range of $23.0150 to $23.6750 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 16:09 UTC |
Busky Joseph M.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001385091-26-000006 · wk-form4_1770757795.xml · derivative · entry 4 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,969 Underlying: Common Stock · 5,968 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 5,968 shares vested on each of February 8, 2025 and February 8, 2026; and the remaining 5,969 shares will vest on February 8, 2027. F4 · derivative.expiration_date: 5,968 shares vested on each of February 8, 2025 and February 8, 2026; and the remaining 5,969 shares will vest on February 8, 2027. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 16:09 UTC |
Busky Joseph M.Chief Financial Officer
|
Tax withholdingCommon Stock | 1,806 | $29.10 | $52,554.60 |
DisclosureSEC source: 0001385091-26-000006 · wk-form4_1770757795.xml · nonDerivative · entry 2 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,412 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 16:09 UTC |
Busky Joseph M.Chief Financial Officer
|
GrantCommon Stock | 5,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001385091-26-000006 · wk-form4_1770757795.xml · nonDerivative · entry 1 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,218 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 16:10 UTC |
Hodges Michelle AChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-26-000006 · wk-form4_1770757821.xml · derivative · entry 3 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,198 Underlying: Common Stock · 3,198 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 3,197 shares vested on February 8, 2025; 3,198 shares vested on February 8, 2026; and the remaining 3,198 shares will vest on February 8, 2027. F4 · derivative.expiration_date: 3,197 shares vested on February 8, 2025; 3,198 shares vested on February 8, 2026; and the remaining 3,198 shares will vest on February 8, 2027. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 16:10 UTC |
Hodges Michelle AChief Legal Officer
|
Tax withholdingCommon Stock | 1,148 | $29.10 | $33,406.80 |
DisclosureSEC source: 0001833942-26-000006 · wk-form4_1770757821.xml · nonDerivative · entry 2 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,605 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.